5 Best Hard Landing Stocks to Buy Now

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 83

Johnson & Johnson (NYSE:JNJ) is an American healthcare company that operates via Pharmaceutical and MedTech segments. 2022 marks the 60th annual dividend increase by Johnson & Johnson (NYSE:JNJ), making it a reliable dividend stock. Johnson & Johnson (NYSE:JNJ) has a history of outperformance amid previous economic crises, which makes it an ideal stock to consider for a hard landing. Daiwa initiated coverage of Johnson & Johnson (NYSE:JNJ) on June 22 with an Outperform rating and a $180 price target.

On April 19, Johnson & Johnson (NYSE:JNJ) declared a $1.13 per share quarterly dividend, a 6.6% increase from its prior dividend of $1.06. The dividend was distributed to shareholders on June 7. The stock delivers a dividend yield of 2.54% as of July 5. 

Among the hedge funds tracked by Insider Monkey, 83 funds were bullish on Johnson & Johnson (NYSE:JNJ) at the end of Q1 2022, with combined stakes worth $7.40 billion. Peter Rathjens, Bruce Clarke, and John Campbell’s Arrowstreet Capital is the largest shareholder of the company, with 6.65 million shares worth about $1.18 billion. 

You can also take a look at Jim Cramer Recommends These 10 Stocks For Recession and Investors Are Watching These 10 Biotech Stocks

Page 5 of 5